Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Infracapital on the acquisition of Falbygdens Energi
Mandate

Vinge advises Infracapital on the acquisition of Falbygdens Energi

December 02, 2013

Vinge is advising Infracapital, a leading European infrastructure investor, managed by M&G Investment Management, the European investment management arm of Prudential plc in connection with the acquisition of Falbygdens Energi AB from Göteborg Energi AB.

Falbygdens Energi AB operates primarily within the Swedish municipality of Falköping. The business operations comprise mainly of the production and distribution of district heating and the distribution of electricity in the area. The electricity distribution network comprises 522 kilometres of overhead lines and 1,690 kilometres of underground cables. FEAB also operates a broadband business in the municipality.

Johan Göthberg was the responsible partner together with associates Matthias Pannier, Lisa Antman, Joel Zetterström, Gabriel Westin, Emma Kero Ljungberg and counsel Robert Deli. Partner Thomas Sjöberg and associate Sofia Ekdahl are advising on real estate and environmental questions.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026